-
-
-
-
-
-
-
Evotec SE raises €116.1 million through convertible bond placement
-
-
-
-
-
-
-
Evotec Announces New Nomination to Board of Directors
-
-
-
-
-
-
-
BofA Securities on Evotec (EVO): guidance 'embeds a high degree of reliance on 2H recovery'
-
-
-
-
-
-
-
Evotec Receives $10 M Milestone from Bristol Myers Squibb Protein Degradation Collaboration for Clinical Study Initiation
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Evotec (EVO)
-
-
-
-
-
-
-
Comment on Media Report
-
-
-
-
-
-
-
Evotec and Bristol Myers Squibb Expand Proteomics Partnership
-
430,619 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

